RY

114.54

+0.77%ā†‘

TD

59.9

+0.94%ā†‘

BMO

97.57

+1.15%ā†‘

BNS

47.47

+1.13%ā†‘

CM

57.93

+1.69%ā†‘

RY

114.54

+0.77%ā†‘

TD

59.9

+0.94%ā†‘

BMO

97.57

+1.15%ā†‘

BNS

47.47

+1.13%ā†‘

CM

57.93

+1.69%ā†‘

RY

114.54

+0.77%ā†‘

TD

59.9

+0.94%ā†‘

BMO

97.57

+1.15%ā†‘

BNS

47.47

+1.13%ā†‘

CM

57.93

+1.69%ā†‘

RY

114.54

+0.77%ā†‘

TD

59.9

+0.94%ā†‘

BMO

97.57

+1.15%ā†‘

BNS

47.47

+1.13%ā†‘

CM

57.93

+1.69%ā†‘

RY

114.54

+0.77%ā†‘

TD

59.9

+0.94%ā†‘

BMO

97.57

+1.15%ā†‘

BNS

47.47

+1.13%ā†‘

CM

57.93

+1.69%ā†‘

Search

XP Inc (Class A)

Gesloten

SectorFinanciƫn

14.02 -0.85

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

13.8

Max

14.18

Belangrijke statistieken

By Trading Economics

Inkomsten

-32M

1.2B

Verkoop

2.3B

4.2B

K/W

Sectorgemiddelde

9.615

22.015

EPS

2.23

Dividendrendement

4.73

Winstmarge

27.809

EBITDA

-158M

1.5B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+13.07% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

4.73%

3.90%

Volgende Winsten

20 mei 2025

Volgende dividenddatum

7 apr 2025

Volgende Ex Dividend datum

8 apr 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

490M

8B

Vorige openingsprijs

14.87

Vorige sluitingsprijs

14.02

Nieuwssentiment

By Acuity

50%

50%

223 / 542 Rangschikking in Finance

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

XP Inc (Class A) Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 feb 2025, 21:39 UTC

Winsten

XP 4Q EPS BRL2.23 >XP

18 feb 2025, 21:38 UTC

Winsten

XP 4Q Rev BRL4.48B >XP

19 nov 2024, 21:11 UTC

Winsten

XP Inc. 3Q EPS BRL2.18 >XP

19 nov 2024, 21:11 UTC

Winsten

XP Inc. 3Q Rev BRL4.54B >XP

1 nov 2024, 11:30 UTC

Top Nieuws

S&P 500 Futures Climb In Premarket Trading; Atlassian, XP Lead

13 aug 2024, 21:00 UTC

Winsten

XP 2Q Rev BRL4.22B >XP

13 aug 2024, 21:00 UTC

Winsten

XP 2Q EPS BRL2.03 >XP

21 mei 2024, 20:03 UTC

Winsten

XP 1Q EPS BRL1.85 >XP

21 mei 2024, 20:03 UTC

Winsten

XP 1Q Rev BRL4.27B >XP

Peer Vergelijking

Prijswijziging

XP Inc (Class A) Prognose

Koersdoel

By TipRanks

13.07% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 16Ā USDĀ  13.07%

Hoogste 20Ā USD

Laagste 13Ā USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor XP Inc (Class A) - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

6 ratings

2

Buy

4

Hold

0

Sell

Technische score

By Trading Central

13.735 / 14.65Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Weak Bullish Evidence

Lange Termijn

Bullish Evidence

Sentiment

By Acuity

223 / 542 Rangschikking in Financiƫn

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over XP Inc (Class A)

XP Inc. is a Cayman Islands-based holding company. The Company owns technological platforms for investments, financial services and education, in addition to media and content platforms, including brands, such as XP, Rico, Clear, Infomoney, XPeed and IM+. It distributes a range of financial products and services, such as financial education and digital content platform, financial advisory services and open financial product platform. Xpeed is a financial education platform in Brazil, which offers courses, MBAs and learning tools, as well as a range of digital content. It advises and supports its customers in a range of activities related to the financial universe, such as advisory services for institutional clients, private banking for high income clients, international financial services, structuring and issuance of financial products for corporate clients and issuers. It offers an open financial product platform to its clients, encompassing both proprietary and partnership products.